Richard Bernstein Advisors LLC Sells 3,985 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Richard Bernstein Advisors trimmed its stake by 46.8% in Intuitive Surgical during Q3, selling 3,985 shares and leaving 4,531 shares valued at about $2.03 million.
• Company insiders have been net sellers — including SVP Mark Brosius (648 shares) and EVP Myriam Curet (421 shares) — with insiders selling 37,261 shares worth $19.69 million over the past 90 days (insider ownership 0.70%).
• Intuitive beat quarterly estimates (EPS $2.53 vs. $2.27; revenue $2.87B vs. $2.72B) and carries a consensus rating of “Moderate Buy” with an average analyst target of $615.86.

Richard Bernstein Advisors LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 46.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,531 shares of the medical equipment provider's stock after selling 3,985 shares during the quarter. Richard Bernstein Advisors LLC's holdings in Intuitive Surgical were worth $2,026,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Tobam boosted its stake in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in Intuitive Surgical in the 2nd quarter worth about $27,000. Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at about $27,000. Caitlin John LLC bought a new position in shares of Intuitive Surgical in the third quarter worth approximately $30,000. Finally, Guerra Advisors Inc purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $37,000. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 648 shares of the business's stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $495.20, for a total transaction of $320,889.60. Following the completion of the sale, the senior vice president owned 2,906 shares of the company's stock, valued at $1,439,051.20. The trade was a 18.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the completion of the sale, the executive vice president directly owned 409 shares in the company, valued at $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 37,261 shares of company stock worth $19,690,721. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms recently commented on ISRG. Argus reduced their price objective on Intuitive Surgical from $630.00 to $560.00 and set a "buy" rating for the company in a report on Wednesday, February 4th. The Goldman Sachs Group reiterated a "buy" rating and issued a $714.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 9th. Zacks Research raised Intuitive Surgical from a "hold" rating to a "strong-buy" rating in a report on Thursday, February 19th. Weiss Ratings restated a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Finally, Sanford C. Bernstein increased their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an "outperform" rating in a research note on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $615.86.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $493.53 on Tuesday. The company has a market capitalization of $175.27 billion, a PE ratio of 62.55, a P/E/G ratio of 3.78 and a beta of 1.66. The company has a 50-day simple moving average of $520.00 and a two-hundred day simple moving average of $512.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts' consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion. During the same period last year, the business posted $2.21 earnings per share. The firm's revenue was up 18.8% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.